← Back to Search

Enhanced Cluster Detection Methods for Outbreak Control (CLUSTER Trial)

N/A
Waitlist Available
Led By Richard Platt, MD, MS
Research Sponsored by Harvard Pilgrim Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 months
Awards & highlights

CLUSTER Trial Summary

This trial will assess whether an automated, statistically-based cluster detection method can help contain hospital clusters.

Who is the study for?
The CLUSTER Trial is for U.S. HCA Healthcare hospitals providing inpatient care and reporting to a centralized data warehouse during the study period. It's not specified which facilities can't participate, suggesting all eligible ones can join.Check my eligibility
What is being tested?
This trial tests an automated statistical method for detecting hospital-associated outbreaks against routine methods. The goal is to see if this new approach helps contain outbreaks faster by reducing their size and duration.See study design
What are the potential side effects?
Since this trial involves institutions rather than individuals, 'side effects' are not applicable in the traditional sense of medical interventions.

CLUSTER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cluster size
Secondary outcome measures
Cluster duration
Other outcome measures
Genetic relatedness of clusters of microbial isolates
Pathogen subgroup analysis

CLUSTER Trial Design

2Treatment groups
Active Control
Group I: Enhanced cluster detectionActive Control1 Intervention
Hospitals will use an automated statistical cluster detection tool in addition to routine practices for cluster detection with a structured cluster response protocol when a cluster is detected.
Group II: Routine cluster detectionActive Control1 Intervention
Hospitals will use routine practices for cluster detection with a structured cluster response protocol when a cluster is detected.

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,477,579 Total Patients Enrolled
Harvard School of Public Health (HSPH)OTHER
271 Previous Clinical Trials
16,304,484 Total Patients Enrolled
Hospital Corporation of America (HCA) HealthcareUNKNOWN

Media Library

Enhanced cluster detection Clinical Trial Eligibility Overview. Trial Name: NCT04053075 — N/A
Cluster Detection Research Study Groups: Enhanced cluster detection, Routine cluster detection
Cluster Detection Clinical Trial 2023: Enhanced cluster detection Highlights & Side Effects. Trial Name: NCT04053075 — N/A
Enhanced cluster detection 2023 Treatment Timeline for Medical Study. Trial Name: NCT04053075 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many clinical sites are conducting this trial?

"Reston Hospital in Reston, Virginia, Parkland Medical Center in Derry, New hampshire, and Trident Regional Medical Center in Charleston, South carolina are three of the sites where this medical experiment is being conducted. Additionally, there are 82 other trial locations participating."

Answered by AI

Are there still openings in this research project?

"Clinicaltrials.gov confirms that this particular medical study, which was initially uploaded on July 23rd 2019 and last modified on January 25th 2022, is currently not recruiting patients. However, there are alternative trials enrolling participants now."

Answered by AI

Who else is applying?

What state do they live in?
Florida
Texas
What site did they apply to?
Medical City Denton
Clearlake Regional Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
1

Why did patients apply to this trial?

~10 spots leftby Dec 2024